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Abstract 
The aim of this study was to characterize
the in vitro osteogenic differentiation of den-
tal pulp stem cells (DPSCs) in 2D cultures and
3D biomaterials. DPSCs, separated from den-
tal pulp by enzymatic digestion, and isolated by
magnetic cell sorting were differentiated
toward osteogenic lineage on 2D surface by
using an osteogenic medium. During differen-
tiation process, DPSCs express specific bone
proteins like Runx-2, Osx, OPN and OCN with
a sequential expression, analogous to those
occurring during osteoblast differentiation,
and produce extracellular calcium deposits. In
order to differentiate cells in a 3D space that
mimes the physiological environment, DPSCs
were cultured in two distinct bioscaffolds,
Matrigel™ and Collagen sponge. With the
addition of a third dimension, osteogenic dif-
ferentiation and mineralized extracellular
matrix production significantly improved. In
particular, in Matrigel™ DPSCs differentiated
with osteoblast/osteocyte characteristics and
connected by gap junction, and therefore
formed calcified nodules with a 3D intercellu-
lar network. Furthermore, DPSCs differentiat-
ed in collagen sponge actively secrete human
type I collagen micro-fibrils and form calcified
matrix containing trabecular-like structures.
These neo-formed DPSCs-scaffold devices may
be used in regenerative surgical applications
in order to resolve pathologies and traumas
characterized by critical size bone defects.
Introduction
Adult stem cells have been isolated from a
variety of human differentiated tissues such
as skin, muscle, adipose tissue, bone marrow
or blood. It was generally accepted that the dif-
ferentiation potential of these stem cells was
restricted to generate cells of the origin line-
age. Recently different authors demonstrate
that adult stem cells show a multilineage dif-
ferentiation potential.1 
Dental pulp stem cells (DPSCs) represent
an adult stem cells population originating from
neural crest cells that reside in the perivascu-
lar niche of dental pulp and constitute a source
of stem cells easily recruitable with low inva-
sivity for the patient.2,3 DPSCs are multipotent
cells that typically express the STRO-1 and
CD146 antigens and are able to differentiate
in osteogenic, chondrogenic, myogenic, adi-
pogenic and neurogenic lineage according to
their embryonic origin.4,5 A c-Kit+/CD34+/STRO-
1+ DPSC multipotent sub-population, particu-
larly able to differentiate in osteogenic line-
age, named SBP-DPSCs, was isolated from
DPSCs by flow cytometry. Osteogenic differen-
tiated SBP-DPSCs express bone tissue specific
proteins, produce calcified extracellular matrix
(ECM) and form nodular cell aggregates and
nodular bone in vitro.6-8
Osteoblast differentiation occurs at differ-
ent stages: it starts with the commitment of
mesenchimal cells (MC) in osteoprogenitor
cells that differentiate in immature osteo -
blasts and then in mature osteoblasts. Specific
transcription factors induce MC to acquire the
osteoblast phenotype and promote the expres-
sion of proteins typical of bone tissue. Runx2
is considered the major transcription factor
controlling osteoblast differentiation. It is
expressed by MC throughout their osteogenic
differentiation, and is also present in mature
osteoblasts. Osterix (Osx) is a zinc finger
transcription factor essential to osteoblast dif-
ferentiation, acting downstream Runx2, and
modulating the expression of important
osteoblast proteins such as osteopontin
(OPN), osteocalcin (OCN), bone sialoprotein
and collagen type I.9-11 OPN is a phospho-pro-
tein containing several calcium binding
domains expressed in differentiating
osteoblasts. During bone development it regu-
lates cell adhesion, proliferation and extracel-
lular matrix (ECM) mineralization.12,13 OCN is
the major protein of bone matrix involved in
the regulation of matrix mineralization. In
bone tissue OCN is not present in areas of first
crystal formation, but in the mineralised ECM.
This suggests that its role may be to control
the size and speed of crystal formation.14
DPSCs osteogenic differentiation was previ-
ously described but the expression analysis of
specific markers was carried out mainly by RT-
PCR techniques. This approach does not give
information about protein synthesized and
secreted by differentiating DPSC (dDPSC)
during the production of calcified ECM.
Protein analysis can elucidate the timing of
synthesis and secretion of specific bone pro-
teins giving further information on the matu-
ration degree of synthesized ECM. Only
recently some papers describe the use of
DPSCs to colonize 3D bio-scaffolds in order to
produce implantable devices.
In this study we analyze the osteogenic dif-
ferentiation of DPSCs on 2D surface in order
to give further evidence regarding their differ-
entiation in osteoblast-like cells. Osteogenic
differentiation was then evaluated by Western
blot and immunofluorescence analysis of
bone-related proteins. The production of calci-
fied ECM was also verified. In a second step, in
order to obtain a stem cell-bioscaffold complex,
we employ DPSCs to colonize two commercial
3D scaffolds: an experimental extracellular
matrix preparation (Matrigel™) and a colla-
gen sponge already used in surgery to improve
tissue regeneration or cicatrisation. DPSCs
seeded in these scaffolds were committed
toward osteogenic lineage in vitro and the
degree of differentiation and the production of
calcified matrix were then evaluated.
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Materials and Methods
All the materials used in this study are list-
ed in Table 1.Cell culture
Cells were isolated from dental pulp as
described in a previous study.8 Human dental
pulp was extracted from third molar or perma-
nent teeth of adult subjects (18 and 35 years of
age) after informed consent of patients under-
going routine extractions. Dental pulp was
removed from the teeth and then immersed in
a digestive solution (3 mg/mL type I collage-
nase plus 4 mg/mL dispase in α-MEM) for 1 h
at 37°C. Once digested, pulp was dissociated
and then filtered onto 100 μm Falcon Cell
Strainers to obtain a cell suspension. Cells
were then plated in 25 cm2 flasks and cultured
in culture medium (α-MEM with 20% FBS, 100
μM 2P-ascorbic acid, 2 mM L-glutamine, 100
U/mL penicillin, 100 μg/mL streptomycin), at
37°C and 5% CO2. Cells obtained from a single
dental pulp were plated at clonal density (1.6
cell/cm2). After 6 days of culture eight cell pop-
ulations were isolated from nodules originated
by single cells. Cell sorting
DPSCs were obtained by magnetic cell sort-
ing using MACS® separation kit, according to
the manufacturer instructions. Three succes-
sive sorting were performed by using specific
antibodies against: CD34, a marker of stromal
and haemopoietic pluripotent stem cells;15 c-
Kit, the tirosin-kinase receptor of stem cells
factor;16 STRO-1, an antigen present in a stro-
mal cell population containing osteogenic pre-
cursors.17 These primary Abs were detected by
magnetically labelled secondary Abs (anti-
mouse IgG, anti-rabbit IgG and anti-mouse
IgM). For each selection approximately 7¥106
cells were used. Firstly, pulp cell suspension
was sorted by anti-CD34 Ab. CD34+ cells were
expanded and then sorted by using anti-c-Kit
Ab to obtain a CD34+/c-Kit+ population. In the
same way the CD34+/c-Kit+ population was
sorted by anti-STRO-1 Ab to obtain the
CD34+/c-Kit+/STRO-1+ population, that repre-
sents isolated DPSCs. Flow cytometry
The expression of the CD34, c-Kit and
STRO-1 antigens was analyzed by indirect
staining using mouse anti-CD34 IgG, rabbit
anti-c-Kit IgG and mouse anti-STRO-1 IgM, fol-
lowed by sheep anti-mouse-FITC, goat anti-
rabbit-FITC and goat anti-mouseIgM-FITC.
Non-specific fluorescence was assessed by
using normal mouse IgG or IgM followed by the
secondary antibody as described above.
Analyses were performed with a EPICS XL flow
cytometer (Beckman Coulter, Brea, CA, USA).Osteogenic differentiation in vitro
In order to obtain a differentiation into
osteoblast on 2D surface, DPSCs were seeded
at approximately 3000 cells/cm2 on culture
dishes in the osteogenic medium (α-MEM,
supplemented with 10% FBS, 100 μM 2P-ascor-
bic acid, 2 mM L-glutamine, 100 U/mL peni-
cillin and 100 μg/mL streptomycin, 100 nM
dexamethasone, 10 mM β-glycerophosphate).
The medium was changed twice a week.
Control DPSCs were cultured in the same
medium without dexamethasone and β-glyc-
erophosphate. For immunofluorescence exper-
iments DPSCs were differentiated on
Thermanox® plastic coverslips.
Cell counting was performed in control and
in dDPSC of three independent experiments
by a Nikon TE2000 inverted Microscope using
a 10¥ objective and differential interference
contrast (DIC). For each experimental point,
the mean of cell number were calculated and
cell density was expressed as cells/cm2.
Matrigel™ (Becton, Dickinson and Co.)
and collagen sponge (Condress®, Abiogen
Pharma) were used as 3D scaffolds in this
study. Cells were seeded in both scaffolds in an
adequate volume of medium to obtain a start-
ing density of 1000 cell for mm3. For each sam-
ple cells were added to Matrigel™ at 4°C when
it appears as liquid. A total volume of 
400 μL of DPSCs-Matrigel™ was placed in a
12 multiwell plate in order to form a 1 mm
thick layer which was polymerized at 37°C.
DPSCs were injected in a 500 mm3 sample col-
lagen sponge by a micropipette tip in different
points to obtain a homogenous cell distribu-
tion. After 8 h from cells seeding, 2 mL of
osteogenic medium was added to each sample.
Medium changes were made twice at week.
Western blotting 
Whole cell lysates were obtained from undif-
ferentiated and differentiating DPSCs at dif-
ferent times of culture. Cells lysates were
obtained as previously described.18 50 μg of
protein (Bradford assay) for each sample were
separated by 10% or 15% SDS page and then
transferred to nitrocellulose membranes. The
protocols of the Western blot were performed
as described by Sambrook et al.19 Blots were
incubated overnight with one of the following
Abs (diluted 1:1000 in TBS-T + 2% BSA and 3%
milk): anti-CD34, anti-c-Kit, anti-STRO-1,
anti-Runx2, anti-OCN, anti-OPN and anti-Osx.
Membranes were next incubated with peroxi-
dase-labelled anti-rabbit, anti-mouse or anti-
goat secondary Abs diluted 1:5000, for 30 min
at room temperature. All membranes were
visualized using ECL (enhanced chemiolumi-
nescence, Amersham, UK). Anti actin Ab was
used as control of protein loading in timing
experiments. 
To detect secreted OCN (sOCN), each sam-
ple was cultured with 2.5 mL of medium. Two
mL of medium were collected for each sample
at the same time-point and then precipitated
in 10% Trichloroacetic acid (TCA). Pre -
cipitated proteins were re-suspended in 0.1N
NaOH in H2O and then in Sample Buffer.  The
whole protein amount obtained for each sam-
ple was loaded in the SDS page in order to
have as a unique variable proteins secreted
from dDPSCs.
Densitometry was performed on Western
blot (WB) from three independent experi-
ments by NIS software (Nikon, Tokio, Japan).
An equal area (AOI) was selected inside each
band and the mean of gray levels (in a 0-256
scale) was calculated. Data were then normal-
ized to values of background and of control
actin band. 
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Table 1. Materials used in the present study.
Material Company
Cell culture reagents, supplements and SIGMA, St. Louis, MO, USA
digestive enzymes; paraformaldehyde,
Glutaraldehyde, BSA, triton and other common 
reagents; anti actin Ab; Durcupan™ ACM Fluka
FBS Euroclone, Milano, Italy
Matrigel™ BD, Franklin Lakes, NJ, USA
Collagen Sponge Condress® Abiogen Pharma, Pisa, Italy
MACS® sorting kit and magnetically Miltenyi biotech, Bergisch Gladbach, Germany
labelled secondary Abs
Thermanox® coverslips Nalge Nunc International, Naperville, IL, USA
Mouse anti-CD34; anti human type I collagen Millipore Corporation, Boronia, Victoria, AU
Rabbit anti-c-Kit; mouse IgM anti-STRO-1; Santa Cruz Biotechnology, Santa Cruz, CA, USA
Mouse anti-OPN; 
Rabbit anti-Runx2 Abcam, Cambridge, UK
Rabbit anti-Osx; mouse antiOCN GeneTex, Irvine, CA, USA
Secondaries antibodies Jackson ImmunoResearch, West Grove, PA, USA
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Histology
Samples of 2D or 3D cultures were fixed in
4% Paraformaldehyde in phosphate buffered
saline (PBS) at pH: 7.4 for 15-60 min and then
processed for successive steps. Cells differen-
tiated on coverslides were processed for
immunofluorescence or histological staining.
Matrigel samples were in toto processed, while
collagen samples were processed to obtain 
10 μm thick cryosections. Routine haema-
toxylin and eosin staining was performed on
some samples to analyze morphological
details. For Alizarin red staining, fixed cells
(or cryosections) were incubated for 30 min at
room temperature in a solution containing
0.1% alizarin red and 1% ammonium hydrox-
ide. Counterstaining with fast green was also
performed to visualize cell morphology. Images
of histological samples were obtained by a
Zeiss Axiophot microscope (Zeiss AG, Jena,
Germany), equipped with a Nikon DS-5Mc
CCD colour camera. Immunofluorescence and confocalmicroscopy
Fixed monolayer cells and in toto
Matrigel™ samples were permeabilized
respectively with 0.1% and 1% Triton X-100 in
PBS for 10 min. Permeabilized samples and
cryosections were then blocked with 3% BSA
in PBS for 30 min at room temperature and
incubated with the primary antibodies diluted
in PBS containing 3% BSA (rabbit anti-c-Kit,
mouse anti-CD34, mouse IgM anti-STRO-1;
rabbit anti-Runx2; mouse anti-OPN; rabbit
anti-Osx; mouse anti-OCN) diluted 1:50 for 1 h
at RT. After washing in PBS containing 3%
BSA, the samples were incubated for 1 h at
room temperature with the secondary Abs
diluted 1:200 in PBS containing 3% BSA (don-
key anti-rabbit-AMCA; sheep anti-mouse-FITC,
and goat anti-mouseIgM-Cy5™; donkey anti
rabbit-Cy3™). After washing in PBS, samples
were stained with 1 μg/mL DAPI in H2O for 1
min (not performed in samples treated with
donkey anti-rabbit-AMCA Ab) and then mount-
ed with anti-fading medium (0.21 M DABCO
and 90% glycerol in 0.02 M Tris, pH 8.0).
Negative controls consisted of samples not
incubated with the primary antibody. The
multi-labelling immunofluorescence experi-
ments were carried out avoiding cross-reac-
tions between primary and secondary antibod-
ies.
Fluorescent samples were observed by a
Nikon TE2000 microscope equipped with a
CCD camera Hamamatsu ORCA 285. Images
were captured and processed by NIS software
(Nikon, Tokyo, Japan). Confocal imaging was
performed on a Leica TCS SP2 AOBS confocal
laser-scanning microscope as described by
Maraldi et al.20 The confocal serial sections
were processed with the Leica LCS software to
obtain three-dimensional projections.
Projections from each signal were processed
as previously described.21 The image rendering
was performed by Adobe Photoshop software.Electron microscopy
Samples processed for morphology observa-
tions were fixed in 2.5% glutaraldehyde in
Phosphate buffer (pH: 7.4) for 1 h and post-
fixed in 1% OsO4 for 1 h. Ultrathin sections,
obtained from Durcupan embedded samples,
were stained with uranyl acetate-lead citrate
and then observed by with a Zeiss EM109
Transmission Electron Microscope (Zeiss AG,
Jena, Germany). Immunogold experiments
were performed as described in a previous
study.22 Briefly, samples were fixed in 1% glu-
taraldehyde in Phosphate buffer (pH 7.4) for 1
h, dehydrated in ethyl alcohol (50%, 70%, 90%,
95% and 100%), diaphanized in propylene
oxide and embedded in Durcupan resin.
Human collagen was detected, in ultrathin sec-
tions, by a mouse anti-human type I collagen
Ab revealed by a 10 nm gold labelled anti-
mouse Ab. Statistical analysis
Quantitative or semi-quantitative data were
expressed as mean ± standard deviation (SD).
Differences between two experimental points
or between experiments were evaluated by
Student's t-test. In all analyses, values of
P<0.05 were considered a significant statisti-
cal difference, while values of P<0.01 were
considered a highly significant statistical dif-
ference.
ResultsDPSC isolation
The cells obtained from dental pulp by enzy-
matic digestion were cultured for several days
to isolate DPSCs. The eight cell populations
isolated from nodules, as reported in Materials
and methods section, produce calcified matrix
when maintained in osteogenic medium (data
not shown). Flow cytometry analysis of these
cell populations (Figure 1A) shows that the
percentages of c-Kit+, CD34+ and STRO-1+
cells are 64%, 46% and 98% respectively (mean
values), indicating that the majority of nodule
constituting cells express c-Kit, CD34 and
STRO-1 and then can be considered the SBP-
DPSCs sub-population isolated by Laino et al.23
To improve the percentage of cells express-
ing c-Kit, CD34 and STRO-1, DPSCs were iso-
lated from other cell types by MACS technolo-
gy. To verify if sorted cells are c-Kit+, CD34+
and STRO-1+, flow cytometry and triple
immunofluorescence experiments were per-
formed on selected cells, by using specific
Original paper
Figure 1. DPSCs
selection. A: Diagram
representing the per-
centage of c-Kit,
CD34 and STRO-1
positive cells in eight
different DPC
colonies derived from
clonal density plated
cells. B: Flow cytoflu-
orimetric analysis of
DPSCs sorted by
MACS. The percent-
age of positive cells is
indicated. C: Fluore -
scence image of
DPSCs triple labelled
by anti c-Kit (Blue),
anti-CD34 (green)
and anti-STRO-1
(Red) Abs. Scale bar:
10 μm. D: Western
blot analysis of whole
cell lysates of sorted
DPSC by anti c-Kit,
anti-CD34 and anti-
STRO-1 Abs. Arrows
indicate the specific
bands.
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antibodies (Figure 1). Flow cytometry demon-
strates that MACS sorting improves the per-
centage of CD34+ (plus 20%) and c-Kit+ (plus
34%) cells (Figure 1B). Immunofluorescence
analysis shows that most of the sorted cells are
simultaneously positive to the three antigens
(Figure 1C: Blue for c-Kit, Green for CD34, Red
for STRO-1). Each positive cell shows a diffuse
labelling on the plasma membrane with the
three signals appearing mostly as separate
pixels and without overlap or co-localization.
Only a small number of spots show the co-pres-
ence of two signals probably due to clusteriza-
tion of receptors. The Ab specificity was con-
firmed by WB experiments (Figure 1D).Osteogenic differentiation on 2Dsurface
In order to obtain osteogenic differentia-
tion, DPSCs were plated on a plastic surface at
the density of 3000 cell/cm2 and then cultured
in osteogenic medium for up to 40 days.
Osteogenic differentiation was evaluated by
morphological, biochemical and immunocyto-
chemical methods. DPSCs treated with culture
medium alone represented control cells. 
The differentiating cultures and control
cells were observed by phase contrast
microscopy to evaluate the morphological
changes and the proliferation rate (Figure 2).
Seeded cells show a fibroblast-like morphology
(Figure 2A), proliferate and reach the conflu-
ence as monolayer at day 8 in both differenti-
ating and control cultures. At this time dDPSC
(Figure 2E) show a lower cell density and pres-
ent a more extended cytoplasm (Figure 2B).
After day 8 control cells proliferate actively and
form overlapped layers that become evident at
days 24 and 40 (Figure 2 C,D). On the contrary,
differentiated cells are characterized by a
lower proliferation activity and start to form
nodular aggregates at day 24 (Figure 2F and
inset). At day 40, in differentiated cultures,
mineral deposits appear in the extracellular
space and in nodular aggregates (Figure  2 G,
H). Cell counting indicates that both differen-
tiating and control cells present the same pro-
liferation rate until day 8. Then undifferentiat-
ed DPSCs continue to grow exponentially and
at day 40 reach a density of over 150,000
cells/cm2. On the contrary differentiating cells
show a lower proliferation activity until day 24.
After this time the number of dDPSC slightly
decreases (Figure 2I).  
To verify the commitment and differentia-
tion of DPSCs into osteoblast-like cells, the
presence of specific markers, such as Runx2,
Osx, OPN and OCN, was analyzed by WB in
whole cell lysates of dDPSC. A densitometric
analysis was carried out on the WB bands to
obtain a semi-quantitative analysis of the pro-
tein amount (Figure 3 A,B). Runx2 is
detectable in all the experimental time points
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Figure 2. Growth dynam-
ics of undifferentiated and
dDPSC. Phase contrast
images of control DPSCs
grown in culture medium
alone at 0 (A), 8 (B), 24
(C) and 40 (D) days or
maintained in osteogenic
medium for 8 (E), 24 (F)
and 40 (G, H) days. Scale
bar: 200 μm. I: diagram
representing the prolifera-
tion rate of both undiffer-
entiated and dDPSC. Data
were calculated by three
independent experiments
and presented as the mean
±SD of cell number for
cm2. *P<0.01.
Figure 3. Expression pattern of dDPSC. Western
blot (WB) analysis (A) and densitometry (B) of
Runx2, Osx, OPN and OCN expression in whole
lysates of DPSCs at different time points of cul-
ture. Actin bands demonstrate that an equal
amount of protein was loaded in each line. C: WB
and densitometry of OCN released in culture
medium. Values, calculated on three independent
experiments, are expressed as mean (±SD) of gray
levels of a 0-256 scale. *P<0.01; §P<0.05.
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but presents significant expression peaks. The
two major peaks occur at days 8-16, indicating
the starting of DPSCs differentiation, and a
third peak is evident at day 32. Runx2 amount
decreases at days 24 and 40 suggesting a
down-regulation of this protein. Osx is weakly
present at day 16 and then increases showing
two expression peaks at days 24-32, while at
day 40 the protein level slightly decreases.
OPN is expressed from day 8 to the end of the
experiment, reaching an expression peak at
day 16 and decreasing progressively until day
40. OCN is detectable during DPSC osteogenic
differentiation both in cell lysates and in cul-
ture medium, as secreted protein (sOCN).
This protein is significantly expressed in
whole lysates from day 16 and shows a peak at
day 40 (Figure 3 A,B). In culture medium,
sOCN starts to be present at day 16, increases
at day 24, then decreases at day 32 and reach-
es the highest level at day 40 (Figure 3C). 
Western blot experiments were confirmed
by immunofluorescence analysis. Double
immunofluorescence labelling was carried out
to analyze simultaneously the localization of
OPN and Runx2 in dDPSC (Figure 4 A,F). The
distribution of OCN and Osx (Figure 4 G,L)
was observed in the same manner. During
DPSCs osteogenic differentiation OPN is local-
ized in the cytoplasm, above all in the perinu-
clear region that normally contains the RER
(Figure 4 A,C,E; green signal). Runx2 is local-
ized in the cell nucleus, as demonstrated by
the overlapping with DAPI signal, and the
nucleoplasmic distribution typical of transcrip-
tion factors can be observed (Figure 4 B,D,F
and insets; DAPI, blue signal; Runx2, red sig-
nal). At day 8 it is present approximately in all
cell nuclei, while at day 24, when a strong
decrease was observed by WB, it is mainly
expressed in nodular aggregates, and nuclei of
monolayered cells show a lower labelling. At
day 40 Runx-2 appears heterogenically
expressed at low levels only by some cells
(Figure 4 A,F; red signal). Immunofluo -
rescence analysis using anti-OCN and anti-
Osx Abs also confirm WB data. OCN shows typ-
ical cytoplasmic localization with a pattern
compatible with the distribution of RER
(Figure 4 G,I,K, green signal). Similarly to
Runx2, Osx shows a nucleoplasmic localiza-
tion (Figure 4 H,J,L and insets). It is interest-
ing to note that the signals from two proteins
increase significantly at days 24 and 40
(Figure 4 I,L) and that nodular aggregates are
more labelled than cells of surrounding mono-
layer (Figure 4 I,J). At day 41 we observe sig-
nificant changes of cell morphology with evi-
dent cellular process typical of differentiating
osteoblasts (Figure 4 E,K).
In order to verify if dDPSC are able to pro-
duce calcified matrix, cells were stained with
alizarin red and counterstained with fast
green, to evidence cell morphology. The pres-
ence of calcium deposits becomes evident
after 40 days of culture (Figure 4 M,N) when
nodular aggregates appear stained in
red/orange. It is interesting to note that cells
entrapped in calcium deposits show an osteo-
cyte-like morphology (Figure 4M and inset).
Osteogenic differentiation on 3Dscaffolds
To evaluate DPSCs differentiation in 3D
scaffolds, cells were cultured and differentiat-
ed in two commercial devices: i) BD Matrigel,
a solubilized extracellular matrix preparation
extracted from the Engelbreth-Holm-Swarm
Original paper
Figure 4. Immuno fluo -
rescence and histochemi-
cal analysis of dDPSC. A-
F: Triple fluorescence
images showing signals
from anti-OPN (green),
anti-Runx2 (Red) and
DAPI (Blue) of dDPSC at
8 (A,B), 24 (C,D) and 40
(E,F) days of culture. The
superimposing between
OPN and Runx2 signals is
given in A, C, E while the
overlap between Runx2
and DAPI signals is given
in B, D, F and insets (3x
magnification respect to B,
D and F). G-L: Triple fluo-
rescence images showing
signals from anti-OCN
(green), anti-Osx (Red)
and DAPI (Blue) of
dDPSC at 8 (G,H), 24
(I,J) and 40 (K,L) days of
culture. The superimpos-
ing between OCN and Osx
signals is given in G, I, K
while the overlap between
Osx and DAPI signals is
given in H, J, L and insets
(3x magnification respect
to H, J and L). M-N:
images of 40 days cultured
DPSCs stained with
Alizarin red and Fast
Green (inset in M is a 2x
magnification respect to
M). Scale bar: 20 μm.
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(EHS) mouse sarcoma; ii) Collagen Sponge, a
biomaterial made of insoluble equine type I
collagen, already used in clinical practice as
scaffold to support bone regeneration. Cells
were seeded in both scaffolds at the density of
1000 cell/mm3 and treated for osteogenic dif-
ferentiation for up to 40 days. Cell growth and
osteogenic differentiation were evaluated at
day 40, by histological, immunocytochemical
and ultrastructural methods.
DPSCs seeded into Matrigel appear distrib-
uted in all the volume of the sample, they grow
actively during the first week and form numer-
ous cellular aggregates distributed homoge-
neously throughout the culture plate (Figure
5A). Each cellular aggregate, composed of cells
with spindly-type morphology, shows a core
with a higher cell density than the marginal
area. The peripheral cells are in contact with
cells of the near aggregates and probably inter-
act, forming a cellular network (Figure 5B).
Confocal analysis of immunofluorescence
experiments with anti-OPN and anti-OCN Abs
shows that cells of nodular aggregates express
the two proteins after 40 days of culture
(Figure 5 C,D) indicating that DPSCs are dif-
ferentiating in osteogenic lineage. The
alizarin staining of 40-day samples shows that
nodular aggregates contain calcium deposits
localized in the matrix close to the cells
(Figure 5 E,F). TEM analysis of dDPSC cul-
tured in Matrigel demonstrates that peripheral
cells of nodular aggregates are connected by
junctions probably classifiable as gap-type
(Figure 5 G,H).
H&E staining shows that DPSCs colonize
collagen scaffold, penetrating into the sponge
and proliferating three-dimensionally. Cells
are not homogeneously distributed in the
sponge thickness, showing a higher cell densi-
ty in the superficial layer, that decreases pro-
gressively towards the centre of the sponge
(Figure 5I). Superficial cells have a flattened
morphology and form a thin compact layer of 4-
5 cells. Cell morphology changes from the sur-
face to the sponge centre and becomes pro-
gressively spindle-type with the cellular
process typical of differentiating osteoblasts
(Figure 5J). In the sponge aggregates of colla-
gen fibres are visible, surrounded by cells
resembling trabecular-like structures (Figure
5 I,J arrows).  
Immunocytochemical evaluation of
osteogenic differentiation shows that DPSCs
growing in collagen sponge express both OPN
and OCN osteogenic markers. OPN is strongly
expressed by DPSCs localized in superficial
layers and is less present in the inner ones
(Figure 5K). Cells positive to OPN Ab are
strictly adherent to collagen fibres associated
in trabecular-like structures, as also observed
by H&E staining (arrows). DPSCs localized in
inner layer, presenting an osteoblast-like mor-
phology or localized near trabecular-like struc-
tures, express higher levels of OCN with
respect to superficial cells (Figure 5L). 
Alizarin Red staining shows that calcium
deposits are present in the whole sponge
thickness and much more in trabecular-like
structures (Figure 5 M,N). 
TEM analysis of dDPSC cultured in collagen
sponge demonstrates that cells are inter-con-
nected by gap junction as described for
Matrigel (not shown). The assembling of neo-
synthesized tropo-collagen molecules in colla-
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Figure 5. Microscopical analy-
sis of DPSCs cultured in 3D
scaffolds. A-H: In toto images
of a 1 mm thick Matrigel layer
in which DPSCs was cultured
for 40 days. Stereomicro -
scopical images are shown in A
and B. Confocal images of flu-
orescence signals from anti-
OPN and anti-OCN Abs
superimposed with DAPI sig-
nal are given in C and D
respectively. Alizarin Red
staining is shown in E and F.
TEM images of a probable gap
junction between two dDPSC
is shown in G-H (H represent a
magnification of G). I-N: 10
μm thick cryosections images
of Collagen scaffolds colonized
with dDPSC. H&E images are
shown in I and J. Confocal
images of fluorescence signals
from anti-OPN and anti-OCN
Abs superimposed with DAPI
signal are given in K and L
respectively. Arrows in I-K
indicate a trabecular-like
structure surrounded by cells.
Alizarin Red staining is shown
in M and N. A-B: scale bar: 2
mm. C-F and I-N: scale bar:
100 μm. G-H: scale bar: 0.5
μm.
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gen sub-microscopic fibrils is well visible both
in sagittal and in transversal sections (Figure
6 A,B). To verify if sub-microscopic fibrils are
effectively secreted by dDPSC, immunogold
experiments with anti Human collagen I Ab
were carried out. This Ab recognizes collagen I
of Human origin but it does not react with the
equine type I collagen of the sponge (Figure 6
C,D). Immunogold experiments demonstrate
that sub-microscopic fibrils are clearly labelled
by anti-Human collagen I Ab (Figure 6D,
arrows). On the opposite, equine collagen
fibres of the sponge are not labelled by anti
Human collagen I Ab (Figure 6D, arrow head).
Discussion
In this study we analyze the osteogenic dif-
ferentiation features of DPSCs in vitro cul-
tured on 2D surface and in 3D scaffolds.
DPSCs population isolated from dental pulp of
adults’ teeth present in their membrane the c-
Kit, CD34 and STRO-1 antigens and then coin-
cides with the DPSC sub-population (SBP-
DPSCs) described by Laino et al.23 According to
data previously described, osteogenic differen-
tiation of DPSCs was obtained by treatment
with dexamethasone to stimulate cell differen-
tiation, ascorbic acid to stimulate extracellular
matrix synthesis and β-glycerophosphate to
promotes ECM mineralization.4,24 DPSCs
respond to this osteogenic condition with a
strong decrease of proliferation after day 8 of
culture, when the confluence was reached.
After this point control cells proliferate active-
ly forming overlapped layers while dDPSC
grow as monolayer and form typical mineral
deposits and nodules described by other
authors.23 After day 24, the number of dDPSC
shows a slightly reduction probably due to
increase of cell death that normally occur dur-
ing late cell differentiation. 
To verify if morphological observation really
indicates a DPSC osteogenic differentiation
we investigated in dDPSC the expression of
bone related proteins. Recently Yu and co-
workers demonstrated that STRO-1+ DPSCs
can only differentiate in osteogenic lineage,
after the 9th passage, expressing specific
markers.25 Different transcription factors and
proteins typical of bone ECM are expressed
during osteoblast differentiation. Only a small
number of these can be used as stringent
markers because they are clearly expressed in
bone tissue or show typical expression peaks
during osteoblast differentiation. The DPSCs
osteogenic differentiation observed in our
experiments can be distinguished in two phas-
es on the basis of expression of specific mark-
ers like Runx2, Osx, OPN and OCN. The first
phase from day 0 to day 16 is characterized by
a strong expression of Runx2 coupled with a
greater presence of OPN. Runx2 is in fact
expressed in undifferentiated cells but shows
a considerable increase between 8 and 16
days, that coincides with the proliferation
decrease and presumably with the starting of a
late differentiation phase. OPN shows its max-
imum expression level at day 16 in coinci-
dence with Runx2 peak and then decreases
progressively to the end of culture. These
observations indicate that this phase repre-
sents an early stage of osteogenic differentia-
tion according to data that describes high lev-
els of Runx2 and OPN in immature osteo -
blasts.26 The proliferation decrease observed in
this early phase is consistent with the role of
Runx2 that acts as a negative modulator of
osteoblast proliferation.27 In the second phase,
from day 16 to day 40, dDPSC show a low pro-
liferation rate and express a higher amount of
Osx maintained until day 32. The increase of
Osx occurring after Runx2 peaks is consistent
with data describing Osx positively, governed
by Runx2 during osteoblast differentiation.10,26
In this phase the regular increase of intracel-
lular OCN levels and the marked presence of
sOCN in culture medium indicate that dDPSCs
undergo a late differentiation phase character-
ized by an ECM maturation process. Previous
data indicate that OCN is the most specific
marker of late osteoblast differentiation
because it is synthesized only by mature
osteoblasts at the end of matrix maturation
process.28,29 The OPN decrease observed in this
phase was supported by observations demon-
strating the presence of OPN during osteoblast
differentiation and its progressive down-regu-
lation according to its role of mineralization
inhibitor.24,30 In our model, after the first induc-
tion, started by the first Runx2 peaks, other
osteogenic inductions can be promoted by fol-
lowing Runx2 peaks in order to maintain an
immature sub-population of dDPSC that
undergo further terminal differentiation
events. On the other hand immunofluores-
cence data indicate that the decrease of
Runx2, observed by WB at day 24, occurs in the
majority of dDPSCs while its expression is
maintained in cells of nodular aggregates. In
contrast Osx and OCN at day 24 are expressed
both in nodular aggregates and in monolayer
cells. Successively their presence character-
izes almost the entire cell population. This
data suggest that nodular aggregates are con-
temporaneously composed of a sub-population
of immature dDPSC and by a dDPSC popula-
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Figure 6. Ultrastructural analysis of DPSCs cultured in Collagen scaffolds. A-B:
Morphological features of dDPSC in collagen sponge; tropocollagen assembling is shown
in A (sagittal section of sub-microscopic fibrils) and B (transversal section of sub-micro-
scopic fibrils). C-D: Immuno-gold analysis of dDPSC by anti-Human Collagen I Ab. D
represents a magnification of C. In D arrows indicate sub-microscopic fibrils labelled by
anti anti-Human Collagen I Ab (gold particles); arrow head indicates equine collagen
fibres of the sponge not labelled by immunogold reaction. Scale bar: 0.5 μm.
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tion that progressively undergo to terminal dif-
ferentiation. The change of cell morphology at
day 40, characterized by thin and long cellular
process, indicates that dDPSCs are in a very
late differentiation phase. Moreover, Alizarin
Red staining demonstrates that calcified ECM
was produced and in some cases dDPSCs are
entrapped by this and show osteocyte-like mor-
phology. 
An optimal bone formation requires that
osteoblasts grow and differentiate in a three-
dimensional (3D) environment, allowing the
formation of an intercellular network.
Previous studies indicate that osteogenic dif-
ferentiation is improved by culture in 3D scaf-
folds that mime the physiological condition.31-33
Calcified tissue can be produced in vitro using
bone marrow MSC cultured on collagen sponge
or similar bio-scaffolds, already utilized in sur-
gery to support and improve bone regenera-
tion.34-37 Our data obtained by culturing DPSCs
on Matrigel™ and Collagen sponge indicate
that both scaffolds optimize DPSCs growing
and differentiation. The gelatinous structure
of Matrigel mimes the amorphous extracellu-
lar matrix components (proteoglycans and
GAG) and allows DPSC to grow forming three-
dimensional nodules. TEM analysis demon-
strates that peripheral cells of these nodules
are interconnected by gap junction analogous-
ly to osteocyte network observed in bone tis-
sue.38,39 A better result was obtained with colla-
gen sponge because DPSCs colonize this scaf-
fold with a distribution that mimes the bone
histology. Cells of superficial layers are less
differentiated as demonstrated by the clear
expression of OPN that decreases in the inner
layers. Moreover these cells present a very flat
morphology and form a thin superficial layer
that can be compared with the bone perios-
teum. Cells with osteoblast-like morphology
that, unlike superficial cells, express high lev-
els of OCN (late differentiation marker) and
actively neo-synthesize human collagen, are
present in the inner layers. In this region
structures containing dense collagen fibres
and calcified matrix that resemble bone tra-
beculae, were detectable. 
In this study we demonstrated that DPSCs
are able to differentiate in osteogenic lineage
both in 2D and 3D surfaces, creating
osteoblast-like cells that express specific
osteogenic markers and produce mineralized
ECM. The combination with 3D bioscaffolds
was performed in order to produce a dDPSC-
bioscaffold device that can be easily inserted
by the surgeon during surgical intervention in
order to repair any bone tissue deficiency. This
tissue engineering approach could be a prom-
ising tool to restore bone defects and deficien-
cies that currently are treated surgically
through the application of artificial permanent
implants. In particular the in vitro bone pro-
duction from stem cells may represent a radi-
cal breakthrough in the treatment of congeni-
tal or acquired pathologies and secondary trau-
mas characterized by critical bone mass
defects, which even today resist any medical or
surgical solution. In addition DPSCs can also
be used to colonize prosthesis and orthodontic
implants in order to optimize the osteo-inte-
gration and the efficiency of the implant itself. 
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